Category
Ribociclib
CAS Number
1211443-61-6
Molecular Formula
C₁₄H₁₇ClN₄O
Molecular Weight
292.8 g/mol
Synonym

2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide ;

Keywords
High-Quality Pharmaceutical Reference Standards
Intermediates
Impurities Manufacturer in India
Metabolites.
Pharmaceutical Standards
Fine Chemicals
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Ribociclib Chloro Amide Impurity (CAS No. 1211443-61-6), with a Molecular Formula of C₁₄H₁₇ClN₄O and Molecular Weight of 292.80 g/mol, is a Ribociclib-related impurity reference standard used for API impurity profiling, related substances analysis, impurity identification, analytical method development, and pharmaceutical quality control testing. Manasa Life Sciences, a pharmaceutical impurity reference standards manufacturer and supplier in India, offers this compound for HPLC, LC-MS, NMR, FTIR, and stability-indicating analytical studies.

As a Ribociclib Chloro Amide Impurity Reference Standard Supplier in India, Manasa Life Sciences supports API manufacturers, oncology pharmaceutical companies, CROs, CDMOs, and analytical testing laboratories with Ribociclib impurity standards, anticancer API-related compounds, and pharmaceutical analytical reference materials. Product-specific documentation, including COA, SDS/MSDS, HPLC chromatograms, and spectral characterization reports, may be available upon request. Our reference materials support testing activities aligned with applicable ICH, USP, and EP guidelines, serving pharmaceutical research requirements across India, UAE, GCC countries, Asia, Europe, and Africa.